Extract
Cubist Announces New Cidecin Data Presented At ASM Meeting.
Business Editors/Health/Medical Writers
BIOWIRE2K LEXINGTON, Mass.--(BUSINESS WIRE)--May 21, 2003 Cidecin Shown to be Rapidly Cidal in vitro Against Second VRSA Strain and Synergistic with Oxacillin in vitro; Demonstrates Efficacy in Animal Model of Endocarditis Cubist Pharmaceuticals, Inc. (Na...See the full content of this document
Sponsored links
